US5876454A
(en)
*
|
1993-05-10 |
1999-03-02 |
Universite De Montreal |
Modified implant with bioactive conjugates on its surface for improved integration
|
US5824651A
(en)
*
|
1993-05-10 |
1998-10-20 |
Universite De Montreal |
Process for modification of implant surface with bioactive conjugates for improved integration
|
JP3708567B2
(ja)
*
|
1994-07-20 |
2005-10-19 |
日清紡績株式会社 |
生物学的に活性な物質を固定するための方法
|
US6558798B2
(en)
|
1995-02-22 |
2003-05-06 |
Scimed Life Systems, Inc. |
Hydrophilic coating and substrates coated therewith having enhanced durability and lubricity
|
US5869127A
(en)
*
|
1995-02-22 |
1999-02-09 |
Boston Scientific Corporation |
Method of providing a substrate with a bio-active/biocompatible coating
|
US6179817B1
(en)
|
1995-02-22 |
2001-01-30 |
Boston Scientific Corporation |
Hybrid coating for medical devices
|
US5672638A
(en)
*
|
1995-08-22 |
1997-09-30 |
Medtronic, Inc. |
Biocompatability for solid surfaces
|
US5679659A
(en)
*
|
1995-08-22 |
1997-10-21 |
Medtronic, Inc. |
Method for making heparinized biomaterials
|
US5767108A
(en)
*
|
1995-08-22 |
1998-06-16 |
Medtronic, Inc. |
Method for making improved heparinized biomaterials
|
CA2197375C
(en)
*
|
1996-02-15 |
2003-05-06 |
Yasuhiro Okuda |
Artificial blood vessel
|
IL117934A0
(en)
*
|
1996-04-16 |
1996-08-04 |
Yeda Res & Dev |
Continuous production of allicin
|
US5674236A
(en)
*
|
1996-04-30 |
1997-10-07 |
Medtronic, Inc. |
Lancet for capillary puncture blood samples
|
US5811151A
(en)
*
|
1996-05-31 |
1998-09-22 |
Medtronic, Inc. |
Method of modifying the surface of a medical device
|
US5728751A
(en)
*
|
1996-11-25 |
1998-03-17 |
Meadox Medicals, Inc. |
Bonding bio-active materials to substrate surfaces
|
US5891196A
(en)
*
|
1997-04-16 |
1999-04-06 |
Baxter International Inc. |
Method for actively binding heparin to crosslinked biological tissues
|
US5760130A
(en)
*
|
1997-05-13 |
1998-06-02 |
Molecular Dynamics, Inc. |
Aminosilane/carbodiimide coupling of DNA to glass substrate
|
US6146771A
(en)
*
|
1997-07-01 |
2000-11-14 |
Terumo Cardiovascular Systems Corporation |
Process for modifying surfaces using the reaction product of a water-insoluble polymer and a polyalkylene imine
|
US6197289B1
(en)
|
1997-07-01 |
2001-03-06 |
Terumo Cardiovascular Systems Corporation |
Removal of biologically active agents
|
US20050171478A1
(en)
*
|
1998-01-13 |
2005-08-04 |
Selmon Matthew R. |
Catheter system for crossing total occlusions in vasculature
|
US6221425B1
(en)
|
1998-01-30 |
2001-04-24 |
Advanced Cardiovascular Systems, Inc. |
Lubricious hydrophilic coating for an intracorporeal medical device
|
US6024918A
(en)
*
|
1998-03-13 |
2000-02-15 |
Medtronic, Inc. |
Method for attachment of biomolecules to surfaces of medical devices
|
US20070087028A1
(en)
*
|
1998-04-16 |
2007-04-19 |
Robert Falotico |
Intraluminal devices for the prevention and treatment of vascular disease
|
US6087415A
(en)
*
|
1998-06-11 |
2000-07-11 |
Johnson & Johnson Vision Care, Inc. |
Biomedical devices with hydrophilic coatings
|
US6500481B1
(en)
|
1998-06-11 |
2002-12-31 |
Johnson & Johnson Vision Care, Inc. |
Biomedical devices with amid-containing coatings
|
US6248127B1
(en)
|
1998-08-21 |
2001-06-19 |
Medtronic Ave, Inc. |
Thromboresistant coated medical device
|
AU2414300A
(en)
*
|
1999-01-15 |
2000-08-01 |
Brigham Young University |
Attachment of acid moiety-containing biomolecules to activated polymeric surfaces
|
US6478423B1
(en)
|
1999-10-12 |
2002-11-12 |
Johnson & Johnson Vison Care, Inc. |
Contact lens coating selection and manufacturing process
|
US7220276B1
(en)
*
|
2000-03-06 |
2007-05-22 |
Surmodics, Inc. |
Endovascular graft coatings
|
EP1303559A4
(de)
*
|
2000-07-14 |
2004-06-30 |
Mimotopes Pty Ltd |
Aktivierte, propfcopolymerisierte oberflächen in modularer ausführung
|
US20020111590A1
(en)
|
2000-09-29 |
2002-08-15 |
Davila Luis A. |
Medical devices, drug coatings and methods for maintaining the drug coatings thereon
|
JP5100951B2
(ja)
|
2000-09-29 |
2012-12-19 |
コーディス・コーポレイション |
被覆医用器具
|
US7261735B2
(en)
*
|
2001-05-07 |
2007-08-28 |
Cordis Corporation |
Local drug delivery devices and methods for maintaining the drug coatings thereon
|
US20060222756A1
(en)
*
|
2000-09-29 |
2006-10-05 |
Cordis Corporation |
Medical devices, drug coatings and methods of maintaining the drug coatings thereon
|
US20070276473A1
(en)
*
|
2000-09-29 |
2007-11-29 |
Llanos Gerard H |
Medical Devices, Drug Coatings and Methods for Maintaining the Drug Coatings Thereon
|
US20040213827A1
(en)
*
|
2000-12-21 |
2004-10-28 |
Enns John B. |
Antimicrobial contact lenses and methods for their production
|
US6764505B1
(en)
|
2001-04-12 |
2004-07-20 |
Advanced Cardiovascular Systems, Inc. |
Variable surface area stent
|
US8182527B2
(en)
|
2001-05-07 |
2012-05-22 |
Cordis Corporation |
Heparin barrier coating for controlled drug release
|
US7862495B2
(en)
|
2001-05-31 |
2011-01-04 |
Advanced Cardiovascular Systems, Inc. |
Radiation or drug delivery source with activity gradient to minimize edge effects
|
US6656216B1
(en)
|
2001-06-29 |
2003-12-02 |
Advanced Cardiovascular Systems, Inc. |
Composite stent with regioselective material
|
GB0122393D0
(en)
*
|
2001-09-17 |
2001-11-07 |
Polybiomed Ltd |
Treating metal surfaces to enhance bio-compatibility
|
US20030065377A1
(en)
|
2001-09-28 |
2003-04-03 |
Davila Luis A. |
Coated medical devices
|
ATE428372T1
(de)
*
|
2001-10-15 |
2009-05-15 |
Hemoteq Ag |
Beschichtung von stents zur verhinderung von restenose
|
US7173073B2
(en)
*
|
2002-01-14 |
2007-02-06 |
Johnson & Johnson Vision Care, Inc. |
Ophthalmic devices containing heterocyclic compounds and methods for their production
|
US20030204168A1
(en)
|
2002-04-30 |
2003-10-30 |
Gjalt Bosma |
Coated vascular devices
|
US7169178B1
(en)
|
2002-11-12 |
2007-01-30 |
Advanced Cardiovascular Systems, Inc. |
Stent with drug coating
|
US20040167572A1
(en)
*
|
2003-02-20 |
2004-08-26 |
Roth Noah M. |
Coated medical devices
|
US7527632B2
(en)
*
|
2003-03-31 |
2009-05-05 |
Cordis Corporation |
Modified delivery device for coated medical devices
|
US7629000B2
(en)
|
2003-05-13 |
2009-12-08 |
E.I. Du Pont De Nemours And Company |
Method for making antimicrobial polyester-containing articles with improved wash durability and articles made thereby
|
US20040236416A1
(en)
*
|
2003-05-20 |
2004-11-25 |
Robert Falotico |
Increased biocompatibility of implantable medical devices
|
US20050033417A1
(en)
*
|
2003-07-31 |
2005-02-10 |
John Borges |
Coating for controlled release of a therapeutic agent
|
US7198675B2
(en)
|
2003-09-30 |
2007-04-03 |
Advanced Cardiovascular Systems |
Stent mandrel fixture and method for selectively coating surfaces of a stent
|
US20050137677A1
(en)
*
|
2003-12-17 |
2005-06-23 |
Rush Scott L. |
Endovascular graft with differentiable porosity along its length
|
US20050249776A1
(en)
*
|
2003-12-19 |
2005-11-10 |
Chen Chao C |
Coated aneurysmal repair device
|
US8747881B2
(en)
*
|
2003-12-19 |
2014-06-10 |
Cordis Corporation |
Intraluminal medical devices in combination with therapeutic agents
|
US8652502B2
(en)
*
|
2003-12-19 |
2014-02-18 |
Cordis Corporation |
Local vascular delivery of trichostatin A alone or in combination with sirolimus to prevent restenosis following vascular injury
|
KR100580642B1
(ko)
*
|
2004-01-12 |
2006-05-16 |
삼성전자주식회사 |
표면에 활성화된 카르복실기를 갖는 기판을 이용하여 생물분자를 고체 기판상에 고밀도로 고정화하는 방법 및 그에 의하여 제조되는 마이크로어레이
|
US7303758B2
(en)
|
2004-01-20 |
2007-12-04 |
Cordis Corporation |
Local vascular delivery of mycophenolic acid in combination with rapamycin to prevent restenosis following vascular injury
|
US7806924B2
(en)
*
|
2004-02-18 |
2010-10-05 |
Cordis Corporation |
Implantable structures for local vascular delivery of cladribine in combination with rapamycin for restenosis
|
US20050187608A1
(en)
*
|
2004-02-24 |
2005-08-25 |
O'hara Michael D. |
Radioprotective compound coating for medical devices
|
US8828416B2
(en)
|
2004-03-09 |
2014-09-09 |
Cordis Corporation |
Local vascular delivery of topotecan in combination with rapamycin to prevent restenosis following vascular injury
|
US7695731B2
(en)
|
2004-03-22 |
2010-04-13 |
Cordis Corporation |
Local vascular delivery of etoposide in combination with rapamycin to prevent restenosis following vascular injury
|
US7875282B2
(en)
*
|
2004-03-22 |
2011-01-25 |
Cordis Corporation |
Coated medical device for local vascular delivery of Panzem® in combination with rapamycin to prevent restenosis following vascular injury
|
EP1732619A1
(de)
*
|
2004-03-26 |
2006-12-20 |
SurModics, Inc. |
Zusammensetzung und verfahren zur herstellung von biokompatiblen oberflächen
|
CA2559741A1
(en)
*
|
2004-03-26 |
2005-10-20 |
Surmodics, Inc. |
A medical article having a bioactive agent-releasing component with photoreactive groups
|
US7989490B2
(en)
|
2004-06-02 |
2011-08-02 |
Cordis Corporation |
Injectable formulations of taxanes for cad treatment
|
US7846940B2
(en)
*
|
2004-03-31 |
2010-12-07 |
Cordis Corporation |
Solution formulations of sirolimus and its analogs for CAD treatment
|
US8003122B2
(en)
*
|
2004-03-31 |
2011-08-23 |
Cordis Corporation |
Device for local and/or regional delivery employing liquid formulations of therapeutic agents
|
US8007737B2
(en)
|
2004-04-14 |
2011-08-30 |
Wyeth |
Use of antioxidants to prevent oxidation and reduce drug degradation in drug eluting medical devices
|
US20050232965A1
(en)
*
|
2004-04-15 |
2005-10-20 |
Robert Falotico |
Local administration of a combination of rapamycin and 17 beta-estradiol for the treatment of vulnerable plaque
|
US9561309B2
(en)
|
2004-05-27 |
2017-02-07 |
Advanced Cardiovascular Systems, Inc. |
Antifouling heparin coatings
|
US20060039950A1
(en)
*
|
2004-08-23 |
2006-02-23 |
Zhengrong Zhou |
Multi-functional biocompatible coatings for intravascular devices
|
US20060129225A1
(en)
*
|
2004-12-15 |
2006-06-15 |
Kopia Gregory A |
Device for the delivery of a cardioprotective agent to ischemic reperfused myocardium
|
US20080241208A1
(en)
*
|
2005-06-30 |
2008-10-02 |
Charles Shanley |
Methods, Compositions and Devices For Promoting Anglogenesis
|
US20070026042A1
(en)
*
|
2005-07-29 |
2007-02-01 |
Narayanan Pallasssana V |
System for treating aneurysmal disease
|
US20070048350A1
(en)
*
|
2005-08-31 |
2007-03-01 |
Robert Falotico |
Antithrombotic coating for drug eluting medical devices
|
US8784860B2
(en)
*
|
2005-10-27 |
2014-07-22 |
Cordis Corporation |
Local administration of a combination of rapamycin and cilostazol for the treatment of vascular disease
|
US20070173787A1
(en)
*
|
2005-11-01 |
2007-07-26 |
Huang Mark C T |
Thin-film nitinol based drug eluting stent
|
US20070116736A1
(en)
*
|
2005-11-23 |
2007-05-24 |
Argentieri Dennis C |
Local vascular delivery of PI3 kinase inhibitors alone or in combination with sirolimus to prevent restinosis following vascular injury
|
US7867547B2
(en)
|
2005-12-19 |
2011-01-11 |
Advanced Cardiovascular Systems, Inc. |
Selectively coating luminal surfaces of stents
|
US8069814B2
(en)
|
2006-05-04 |
2011-12-06 |
Advanced Cardiovascular Systems, Inc. |
Stent support devices
|
US8603530B2
(en)
|
2006-06-14 |
2013-12-10 |
Abbott Cardiovascular Systems Inc. |
Nanoshell therapy
|
US8048448B2
(en)
|
2006-06-15 |
2011-11-01 |
Abbott Cardiovascular Systems Inc. |
Nanoshells for drug delivery
|
US8017237B2
(en)
|
2006-06-23 |
2011-09-13 |
Abbott Cardiovascular Systems, Inc. |
Nanoshells on polymers
|
US20090226495A1
(en)
*
|
2007-07-17 |
2009-09-10 |
Picardi Salvatore Charles |
Nanodiamond enhanced efficacy
|
US8506984B2
(en)
*
|
2006-07-26 |
2013-08-13 |
Cordis Corporation |
Therapeutic agent elution control process
|
US20080241215A1
(en)
|
2007-03-28 |
2008-10-02 |
Robert Falotico |
Local vascular delivery of probucol alone or in combination with sirolimus to treat restenosis, vulnerable plaque, aaa and stroke
|
US8048441B2
(en)
|
2007-06-25 |
2011-11-01 |
Abbott Cardiovascular Systems, Inc. |
Nanobead releasing medical devices
|
US20090074831A1
(en)
|
2007-09-18 |
2009-03-19 |
Robert Falotico |
LOCAL VASCULAR DELIVERY OF mTOR INHIBITORS IN COMBINATION WITH PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR STIMULATORS
|
US9603980B2
(en)
|
2008-02-26 |
2017-03-28 |
CARDINAL HEALTH SWITZERLAND 515 GmbH |
Layer-by-layer stereocomplexed polymers as drug depot carriers or coatings in medical devices
|
US8420110B2
(en)
|
2008-03-31 |
2013-04-16 |
Cordis Corporation |
Drug coated expandable devices
|
US8409601B2
(en)
*
|
2008-03-31 |
2013-04-02 |
Cordis Corporation |
Rapamycin coated expandable devices
|
US8273404B2
(en)
*
|
2008-05-19 |
2012-09-25 |
Cordis Corporation |
Extraction of solvents from drug containing polymer reservoirs
|
TWI519845B
(zh)
|
2010-07-30 |
2016-02-01 |
諾華公司 |
具有富水表面之聚矽氧水凝膠鏡片
|
WO2013001096A1
(en)
|
2011-06-30 |
2013-01-03 |
Dsm Ip Assets B.V. |
Silicone-containing monomer
|
HUE029018T2
(en)
|
2011-10-12 |
2017-02-28 |
Novartis Ag |
A method for producing UV absorbing contact lenses by coating
|
SG11201504763UA
(en)
|
2012-12-17 |
2015-07-30 |
Novartis Ag |
Method for making improved uv-absorbing ophthalmic lenses
|
US9757330B2
(en)
|
2013-10-18 |
2017-09-12 |
Industrial Technology Research Institute |
Recipe for in-situ gel, and implant, drug delivery system formed thereby
|
WO2015095157A1
(en)
|
2013-12-17 |
2015-06-25 |
Novartis Ag |
A silicone hydrogel lens with a crosslinked hydrophilic coating
|
EP3186070B1
(de)
|
2014-08-26 |
2019-09-25 |
Novartis AG |
Verfahren zum auftragen einer stabilen beschichtung auf silikonhydrogelkontaktlinsen
|
KR102604468B1
(ko)
|
2015-12-15 |
2023-11-22 |
알콘 인코포레이티드 |
실리콘 하이드로겔 콘택트 렌즈 상에 안정한 코팅을 적용하기 위한 방법
|
HUE057348T2
(hu)
|
2017-12-13 |
2022-05-28 |
Alcon Inc |
Eljárás MPS-kompatibilis hidrogradiens kontaktlencsék elõállítására
|
CN115322429B
(zh)
*
|
2022-08-24 |
2023-07-14 |
天津大学温州安全(应急)研究院 |
一种高抗凝体外循环管路
|